Hundreds of doctors to be investigated for questionable prescribing practicesBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f4076 (Published 24 June 2013) Cite this as: BMJ 2013;346:f4076
- Michael McCarthy
An investigation into physicians’ prescribing practices through Medicare’s drug benefit plan Medicare Part D has identified more than 700 physicians who have “extremely” unusual practices—including writing suspiciously high numbers of prescriptions, often for Schedule II and III drugs.
Schedule II drugs include methadone, oxycodone, and fentanyl, and Schedule III drugs include products that combine non-prescription analgesics, such as paracetamol, with lower dosages of hydrocodone and codeine. Overprescription of these substances is seen as the major cause of the increasing abuse of prescription drugs in the United States.
The investigation was conducted by …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial